ROR1 and breast carcinoma: In a previous study, it was determined that when over-expression of Ror1 without HER2/neu, and hormone receptors on the cell surface were introduced in the breast cancer this protein served as an appropriate candidate for designing a cancer vaccine and it was concluded that Ror1 with an enterotoxin B could be a potent vaccine65.